PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.70%
Revenue growth under 50% of ADI's 14.75%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
171.79%
Gross profit growth above 1.5x ADI's 8.93%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-1233.33%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-1233.33%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-700.00%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-445.24%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-445.24%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.04%
Share reduction more than 1.5x ADI's 7.71%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.04%
Diluted share reduction more than 1.5x ADI's 7.71%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-0.04%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
3256.25%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
223.77%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
34.49%
10Y revenue/share CAGR at 50-75% of ADI's 60.89%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
34.49%
5Y revenue/share CAGR at 50-75% of ADI's 60.89%. Martin Whitman would worry about a lagging mid-term growth trajectory.
10.19%
3Y revenue/share CAGR under 50% of ADI's 30.45%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.93%
Negative 10Y net income/share CAGR while ADI is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-25.93%
Negative 5Y net income/share CAGR while ADI is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-169.92%
Negative 3Y CAGR while ADI is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
52.64%
10Y equity/share CAGR above 1.5x ADI's 31.76%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
52.64%
5Y equity/share CAGR above 1.5x ADI's 31.76%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
31.37%
3Y equity/share CAGR above 1.5x ADI's 8.28%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-15.63%
Cut dividends over 10 years while ADI stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-15.63%
Negative 5Y dividend/share CAGR while ADI stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
56.25%
3Y dividend/share CAGR of 56.25% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-19.11%
Firm’s AR is declining while ADI shows 17.03%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.00%
Inventory is declining while ADI stands at 23.68%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.45%
Asset growth well under 50% of ADI's 7.01%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-3.32%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-4.34%
We’re deleveraging while ADI stands at 193.33%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
10.16%
SG&A declining or stable vs. ADI's 46.88%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.